Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AtriCure (ATRC) Shares Outstanding (Diluted Average) (2019 - 2025)

AtriCure (ATRC) has disclosed Shares Outstanding (Diluted Average) for 7 consecutive years, with $47.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 1.67% to $47.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $47.8 million, a 1.67% increase, with the full-year FY2025 number at $47.8 million, up 1.67% from a year prior.
  • Shares Outstanding (Diluted Average) was $47.8 million for Q4 2025 at AtriCure, roughly flat from $47.7 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $47.8 million in Q4 2025 to a low of $44.6 million in Q1 2021.
  • A 5-year average of $46.4 million and a median of $46.2 million in 2023 define the central range for Shares Outstanding (Diluted Average).
  • Peak YoY movement for Shares Outstanding (Diluted Average): increased 11.24% in 2021, then dropped 0.91% in 2022.
  • AtriCure's Shares Outstanding (Diluted Average) stood at $46.0 million in 2021, then dropped by 0.65% to $45.7 million in 2022, then grew by 1.24% to $46.3 million in 2023, then rose by 1.42% to $47.0 million in 2024, then grew by 1.67% to $47.8 million in 2025.
  • Per Business Quant, the three most recent readings for ATRC's Shares Outstanding (Diluted Average) are $47.8 million (Q4 2025), $47.7 million (Q3 2025), and $47.7 million (Q2 2025).